Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00022854 · ClinicalTrials.gov registry record · Phase 4
Pain Relief Results After Anterior Cruciate Ligament (ACL) Reconstruction
A Phase 4 study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 4
- Development phase
- 270
- Enrollment target
NCT00022854 is a Phase 4 study that has completed, run by University of Pittsburgh. The registered enrollment target is 270 participants.
The verdict
NCT00022854, a Phase 4 study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 270 participants
- Enrollment target
Study Summary
Anterior cruciate ligament (ACL) reconstruction is surgery that is done to repair a damaged ligament in the knee. In this study we will look at whether the femoral nerve block, a commonly used method for pain relief after ACL reconstruction, affects the way patients feel after surgery. We will study recovery during the first week after surgery and also 3-12 weeks after surgery. We will give all patients spinal anesthesia. Some patients will also receive a continuous femoral nerve block for 2 days, or by a single injection. We predict that patients who received the nerve block will have significantly improved pain results, compared to patients who did not receive the nerve block.
Interventions
- PROCEDURE Single-injection femoral nerve block
- PROCEDURE Femoral nerve block 60-hour continuous injection
- PROCEDURE Saline (control) injection into femoral nerve envelope
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2001-05 |
| Est. Completion | 2005-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00022854
The ClinicalTrials.gov registry entry for NCT00022854 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 270 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Single-injection femoral nerve block is the first listed.
NCT00022854 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00022854 about?
NCT00022854 is a clinical study titled "Pain Relief Results After Anterior Cruciate Ligament (ACL) Reconstruction". Anterior cruciate ligament (ACL) reconstruction is surgery that is done to repair a damaged ligament in the knee. In this study we will look at whether the femoral nerve block, a commonly used method for pain relief after ACL reconstruction, affects the way patients feel after surgery. We will study...
What is the current status of trial NCT00022854?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 270 participants. The study started on 2001-05. Estimated completion is 2005-01.
What interventions are being tested in trial NCT00022854?
The interventions under investigation include: Single-injection femoral nerve block (PROCEDURE), Femoral nerve block 60-hour continuous injection (PROCEDURE), Saline (control) injection into femoral nerve envelope (PROCEDURE).
Who is sponsoring clinical trial NCT00022854?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.